Danske Bank announces its new Forward ‘28 strategy and financial targets for 2026
|Company announcement no. 4 2023||Danske Bank A/S|
Holmens Kanal 2 – 12
DK-1092 København K
Tel. +45 45 14 00 00
7 June 2023
Danske Bankannounces its newForward ‘28strategy and financial targets for 2026
In recent years, Danske Bank has made fundamental changes to the bank, resulting in a more focused business with a reduced risk level and a strengthened organisation. Simultaneously we have focused on strengthening our commercial momentum, and Danske Bank is on a clear trajectory to exceed the original financial targets we set for 2023.
Today Danske Bank is a focused Nordic bank with a strong market presence in Denmark, Sweden, Finland, and Norway. With our new strategy, we set clear ambitions to continue our efforts to strengthen our position as a leading bank in the Nordic region and make significant investments in customer offerings. For business and institutional customers, we want to be a leading bank in Denmark, Sweden, Finland and Norway. For retail and private banking customers, we will with a sharpened focus in each market continue our strategic development to strengthen our relations with existing customers and attract new ones:
- Denmark: We want to reaffirm our position as the bank of choice across customer segments.
- Finland: We want to maintain our position, serving customer needs across a broad set of segments and focusing on customers with advanced needs in primarily urban areas.
- Sweden: We want to become the premium retail and private banking bank for business owners and customers with advanced needs.
- Norway: We have decided to exit the market for personal customers in Norway to focus our efforts, investments and capital on other parts of our portfolio (see Company Announcement no. 5 2023).
2026 financial targets and capital distribution
We have set new financial targets for 2026, which reflect our ambition to deliver a solid return on equity, continue to simplify and raise efficiency, lower costs and to consistently generate and distribute capital to our shareholders based on low risk levels:
- Return on equity: 13% with a CET1 ratio of above 16%
- Cost/income ratio: around 45%
Our capital distribution policy of a dividend pay-out of 40-60% of net profit remains unchanged. From 2023-2026, we see a total dividend potential of at least DKK 50 billion, based on the upper end of our dividend policy range.
For 2023-2026, we have the ambition of making further capital distribution subject to our capital position and market conditions.
In accordance with the above, Danske Bank intends to restart dividend payments with the announcement of the interim report for the first half of 2023. The intended dividend payment will be based on the net profit for the first half of 2023, and we will be targeting the upper end of the 40-60% dividend policy range. The intended capital distribution is subject to a decision by the Board of Directors in accordance with the authorisation granted to the Board of Directors and will be based on a prudent assessment of Danske Bank’s capital position at the end of the first half of 2023.
Our financial targets are based on a prudent set of assumptions for the macroeconomic development and an expected growth in lending of approximately 3% and in deposits of less than 1%.
To support the execution of the strategy, we are significantly increasing our annual investments in our core capabilities within digital platforms, expert advisory services and sustainability from DKK 3 billion to DKK 4 billion. Combined with the reprioritisation of other investments, this means that we more than double our investments in the strategic development of the bank.
Carsten Egeriis, CEO of Danske Bank:
“Danske Bank has during recent years made fundamental changes to refocus the bank, reduce our risk exposure, develop our organisation and accelerate our commercial momentum. We can see that the changes work andwe areon a clear trajectory to exceed the original financial targets we set for 2023.”
“We are changing gears and substantially increasing our strategic and financial ambitions. We continue to accelerate our commercial momentum in all parts of the business,underpinned by clear growth and profitability targets. At the same time, we have decided to significantly increase our investments in our digital platforms, expert advisory servicesand sustainability, focusing on the areas where we see the best opportunities for profitable growth.”
“Withour new strategy, we set clear ambitions for Danske Bank tobe a leading bank in a digital age. Servinga quarter of the personal customers in our home market, we will work hard to continue to earntheir trust and to affirm our position as the bank of choice in Denmark.”
Stephan Engels, CFO of Danske Bank:
“Danske Bank is determined to deliver shareholder value and with the good momentum we have in our business, we expect to have substantial future distribution potential for dividends. We intend to restart dividend payments whenwe announce our results for the first half of 2023, and from 2023 to 2026, we see a potential for a total dividend equivalent to the upper level of our dividend policy range, which remains unchanged at 40-60%.”
Today, 7 June 2023 at 8.00am-12.00 noon CEST, Danske Bank’s Executive Leadership Team hosts an investor update and presents the new strategic direction and 2026 financial targets and host a Q&A session.
The investor update can be followed online, and all presentations will be recorded and made available on our website afterwards.
Contact: Helga Heyn, Interim Head of Media Relations, tel. +45 45 14 14 00
Claus I. Jensen, Head of Investor Relations, tel. +45 25 42 43 70
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Nyxoah Strengthens its Executive Leadership Team28.11.2023 22:30:00 CET | Press release
Nyxoah Strengthens its Executive Leadership Team Francis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis Kim as Chief Regulatory and Quality Officer. Francis will be leading Nyxoah’s Global Regulatory and Quality departments. Francis is a highly experienced global regulatory and quality executive in the healthcare industry, having spent more than 25 years in the medical device and life sciences sector. Francis has led Regulatory and Quality departments at Medtronic, Philips, and other companies, including introducing several innovative products and therapies to the market. “Nyxoah is entering the most exciting time in the Company’s history, with data fro
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update28.11.2023 22:15:00 CET | Press release
Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab)The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European CommissionApprovability of AVT02 and AVT04 in the U.S. now pending satisfactory US Food and Drug Administration (FDA) inspection of Alvotech’s facility in Iceland, currently expected on January 10 – 19, 2024Management will conduct a business update conference call and live webcast on Thursday November 29, 2023, at 8:00 am ET (13:00 pm GMT) Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of 2023 and pr
RÄTTELSE: Saknad MAR-etikett i tidigare pressmeddelande – ”Anoto ingår ett avtal för 1,1 miljoner USD avseende försäljning av pennor och treåriga mjukvarulicenser med Deutsche Telekom”28.11.2023 19:15:00 CET | Pressemelding
Anoto Group AB (publ) utfärdar en rättelse av pressmeddelandet som publicerades tidigare idag. Rättelsen avser att pressmeddelandet saknade MAR-etikett med hänvisning till EU:s marknadsmissbruksförordning (MAR). Följande information skulle ha varit med i pressmeddelandet: ”Denna information är sådan information som Anoto Group AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades genom ovanstående kontaktpersons försorg för offentliggörande den 28 november 2023, kl. 08:00 CEST.” Nedan publiceras det korrekta pressmeddelandet i sin helhet. Stockholm den 28 november 2023 – Anoto Group AB (publ) ("Anoto" eller "Bolaget") meddelar idag att bolaget har tecknat ett upphandlingsavtal som avser försäljning av nya pennor, samt ett treårigt mjukvarulicensavtal med Deutsche Telekom AG (”Deutsche Telekom”). Deutsche Telekom är en av de äldsta kunderna inom Anotos affärssegment Forms och avtalet innebär att ramverket inom vilket Anoto och Deutsche T
CORRECTION: Missing MAR label in previous press release – “Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom”28.11.2023 19:15:00 CET | Press release
Anoto Group AB (publ) issues a correction to the press release published earlier today. The correction refers to the fact that the press release lacked a MAR label with reference to the EU Market Abuse Regulation (MAR). The following information should have been included in the press release: ”This information constitutes inside information as Anoto Group AB (publ) is obliged to disclose under the EU Market Abuse Regulation 596/2014. The information was provided by the contact person above for publication 28 November 2023, at 08:00 CEST.” The correct press release is published in its entirety below. Stockholm, 28 November 2023 – Anoto Group AB (publ) ("Anoto" or the "Company") today announces that it has signed a procurement agreement relating to the sale of new pens, plus a new three-year software licensing agreement with Deutsche Telekom AG (“Deutsche Telekom”). Deutsche Telekom is one of the oldest customers of Anoto’s Forms business and this agreement means that the framework withi
Status for Selskabets tilgodehavende hos Portinho S.A.28.11.2023 18:30:48 CET | pressemeddelelse
28. november 2023 Meddelelse nr. 46 Status for Selskabets tilgodehavende hos Portinho S.A. Selskabets bestyrelse, valgt ind i forbindelse med at Selskabet blev omdannet til en lægemiddelvirksomhed, og direktion har i længere tid, haft en meget tæt dialog med ledelsen i Portinho S.A. om indfrielse af Selskabets tilgodehavende hos Portinho S.A., der stammer fra tiden før Selskabet blev omdannet til en lægemiddelvirksomhed. Selskabets bestyrelse og direktion har sideløbende allokeret betydelige ressourcer til at afdække, hvilke dispositioner der fra den tidligere ledelse oprindeligt førte til etableringen af tilgodehavendet samt rationalet for de efterfølgende dispositioner af den tidligere ledelse, der har indvirket på tilgodehavendets vandring. Dette arbejde pågår forsat med blandt andet bistand fra både dansk og portugisisk juridisk rådgiver. Omfanget og vurderingen af de foreløbige resultater af undersøgelsesarbejdet har ført til, at det ikke længere er Selskabets vurdering, at tilgod